The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See More
The site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST).
If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
See MoreThe site is undergoing maintenance. Ordering can continue through fax and phone.
Sunday, August 16, 2026, 1:30 - 4:30 pm (CEST)
.If you encounter problems while ordering. Please contact us at BDBCustomerService@bd.com
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of CD45RO expression on human peripheral blood lymphocytes.
Left Panel: Whole blood was stained with Alexa Fluor® 700 Mouse Anti-Human CD45RO antibody (Cat. No. 561136; solid line histogram), or with a Alexa Fluor® 700 Mouse IgG2a, κ Isotype Control (Cat. No. 557880; dashed line histogram).
Right Panel: Whole blood was stained with Alexa Fluor® 700 Mouse Anti-Human CD45RO antibody (Cat. No. 561136) in conjunction with a PE Mouse Anti-Human CD45RA antibody (Cat. No. 555489).
Erythrocytes were lysed with BD PharmLyse™ Lysing Buffer (Cat. No.555899). The fluorescence histograms and dot plot were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD45RO expression on human peripheral blood lymphocytes.
Left Panel: Whole blood was stained with Alexa Fluor® 700 Mouse Anti-Human CD45RO antibody (Cat. No. 561136; solid line histogram), or with a Alexa Fluor® 700 Mouse IgG2a, κ Isotype Control (Cat. No. 557880; dashed line histogram).
Right Panel: Whole blood was stained with Alexa Fluor® 700 Mouse Anti-Human CD45RO antibody (Cat. No. 561136) in conjunction with a PE Mouse Anti-Human CD45RA antibody (Cat. No. 555489).
Erythrocytes were lysed with BD PharmLyse™ Lysing Buffer (Cat. No.555899). The fluorescence histograms and dot plot were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD45RO expression on human peripheral blood lymphocytes.
Left Panel: Whole blood was stained with Alexa Fluor® 700 Mouse Anti-Human CD45RO antibody (Cat. No. 561136; solid line histogram), or with a Alexa Fluor® 700 Mouse IgG2a, κ Isotype Control (Cat. No. 557880; dashed line histogram).
Right Panel: Whole blood was stained with Alexa Fluor® 700 Mouse Anti-Human CD45RO antibody (Cat. No. 561136) in conjunction with a PE Mouse Anti-Human CD45RA antibody (Cat. No. 555489).
Erythrocytes were lysed with BD PharmLyse™ Lysing Buffer (Cat. No.555899). The fluorescence histograms and dot plot were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD45RO expression on human peripheral blood lymphocytes.
Left Panel: Whole blood was stained with Alexa Fluor® 700 Mouse Anti-Human CD45RO antibody (Cat. No. 561136; solid line histogram), or with a Alexa Fluor® 700 Mouse IgG2a, κ Isotype Control (Cat. No. 557880; dashed line histogram).
Right Panel: Whole blood was stained with Alexa Fluor® 700 Mouse Anti-Human CD45RO antibody (Cat. No. 561136) in conjunction with a PE Mouse Anti-Human CD45RA antibody (Cat. No. 555489).
Erythrocytes were lysed with BD PharmLyse™ Lysing Buffer (Cat. No.555899). The fluorescence histograms and dot plot were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD45RO expression on human peripheral blood lymphocytes.
Left Panel: Whole blood was stained with Alexa Fluor® 700 Mouse Anti-Human CD45RO antibody (Cat. No. 561136; solid line histogram), or with a Alexa Fluor® 700 Mouse IgG2a, κ Isotype Control (Cat. No. 557880; dashed line histogram).
Right Panel: Whole blood was stained with Alexa Fluor® 700 Mouse Anti-Human CD45RO antibody (Cat. No. 561136) in conjunction with a PE Mouse Anti-Human CD45RA antibody (Cat. No. 555489).
Erythrocytes were lysed with BD PharmLyse™ Lysing Buffer (Cat. No.555899). The fluorescence histograms and dot plot were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD45RO expression on human peripheral blood lymphocytes.
Left Panel: Whole blood was stained with Alexa Fluor® 700 Mouse Anti-Human CD45RO antibody (Cat. No. 561136; solid line histogram), or with a Alexa Fluor® 700 Mouse IgG2a, κ Isotype Control (Cat. No. 557880; dashed line histogram).
Right Panel: Whole blood was stained with Alexa Fluor® 700 Mouse Anti-Human CD45RO antibody (Cat. No. 561136) in conjunction with a PE Mouse Anti-Human CD45RA antibody (Cat. No. 555489).
Erythrocytes were lysed with BD PharmLyse™ Lysing Buffer (Cat. No.555899). The fluorescence histograms and dot plot were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD45RO expression on human peripheral blood lymphocytes.
Left Panel: Whole blood was stained with Alexa Fluor® 700 Mouse Anti-Human CD45RO antibody (Cat. No. 561136; solid line histogram), or with a Alexa Fluor® 700 Mouse IgG2a, κ Isotype Control (Cat. No. 557880; dashed line histogram).
Right Panel: Whole blood was stained with Alexa Fluor® 700 Mouse Anti-Human CD45RO antibody (Cat. No. 561136) in conjunction with a PE Mouse Anti-Human CD45RA antibody (Cat. No. 555489).
Erythrocytes were lysed with BD PharmLyse™ Lysing Buffer (Cat. No.555899). The fluorescence histograms and dot plot were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD45RO expression on human peripheral blood lymphocytes.
Left Panel: Whole blood was stained with Alexa Fluor® 700 Mouse Anti-Human CD45RO antibody (Cat. No. 561136; solid line histogram), or with a Alexa Fluor® 700 Mouse IgG2a, κ Isotype Control (Cat. No. 557880; dashed line histogram).
Right Panel: Whole blood was stained with Alexa Fluor® 700 Mouse Anti-Human CD45RO antibody (Cat. No. 561136) in conjunction with a PE Mouse Anti-Human CD45RA antibody (Cat. No. 555489).
Erythrocytes were lysed with BD PharmLyse™ Lysing Buffer (Cat. No.555899). The fluorescence histograms and dot plot were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Flow cytometric analysis of CD45RO expression on human peripheral blood lymphocytes.
Left Panel: Whole blood was stained with Alexa Fluor® 700 Mouse Anti-Human CD45RO antibody (Cat. No. 561136; solid line histogram), or with a Alexa Fluor® 700 Mouse IgG2a, κ Isotype Control (Cat. No. 557880; dashed line histogram).
Right Panel: Whole blood was stained with Alexa Fluor® 700 Mouse Anti-Human CD45RO antibody (Cat. No. 561136) in conjunction with a PE Mouse Anti-Human CD45RA antibody (Cat. No. 555489).
Erythrocytes were lysed with BD PharmLyse™ Lysing Buffer (Cat. No.555899). The fluorescence histograms and dot plot were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD™ LSR II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The UCHL1 monoclonal antibody specifically binds to the 180 kDa isoform of CD45 (aka, the Leukocyte Common Antigen). CD45RO is a type I transmembrane glycoprotein that has cytoplasmic protein tyrosine phosphatase activity and functions in signal transduction pathways. This CD45 isoform does not include amino acid sequences encoded by the variable CD45 exons A, B, or C. CD45RO is expressed on most thymocytes, activated T cells, memory T cells, granulocytes and monocytes, but only on a proportion of resting T cells. CD45RO and CD45RA antibodies seem to define complementary, predominantly non-overlapping, populations in resting peripheral T cells, demonstrating heterogeneity within the CD8 and CD4 subpopulations. CD45RO binds to CD22.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.